Envomed team helps HUSLAB unlock Envomed 80 performance advantages during Helsinki visit
The Envomed team travelled to Helsinki last week, to help the HUSLAB team unlock all of the performance advantages offered by the Envomed 80 sustainable on-site medical waste treatment solution installed at the HUS Helsinki University Hospital.
The visit was focused around bespoke-designed product training – not only on the functionality and maintenance of the Envomed machine, but also on the Performance Verification processes that allows HUSLAB to be confident the Envomed 80 is successfully sterilizing their waste to STAATT level IV each and every time.
David Segev, Envomed CEO commented: “The Envomed team is incredibly proud that our Envomed 80 on-site medical waste treatment solution is already making a sustainable difference at HUS.
Our sessions with the HUSLAB team were incredibly productive, offering important insights into how to drive optimal performance from their Envomed 80 on-site medical waste treatment machine.
It is always exciting to demonstrate the most powerful features of the Envomed 80, including its ability to treat high-content, liquid phase infectious waste and of course the performance verification process.
We look forward to seeing the HUSLAB team achieving fantastic, sustainable savings – both in terms of cost, and environmental footprint – through the optimal performance of their Envomed 80”.
About the Envomed 80
The Envomed 80 is a scientifically driven, onsite solution for Medical Waste treatment. Totally unique in the market today, the Envomed 80 shreds and sterilizes medical waste simultaneously, using a scientifically developed and proven technology which has the ability to sterilize medical waste to STAATT level IV. Offering the HUS Helsinki University Hospital an extremely powerful & environmentally friendly solution, the Envomed 80 can treat 80 litres of infectious and sharps medical waste in under 20 minutes.
Environmentally friendly, the Envomed 80 has a lower carbon footprint than alternative treatment solutions on the market today. It was developed by Maabarot Metal Works Ltd, a company with extensive technical knowledge and over 30 years’ experience in providing specialized industrial machinery.
Identifying the market’s need for efficient on-site medical waste treatment facilities, MMW made significant investments in R&D and engineered a solution that is revolutionary from economic, safety and environmental perspectives.
A non-compromise game changing solution, The Envomed 80 unit offers fully comprehensive validation using both the solid and liquid phases of real infectious waste, including the presence of protein, hemoglobin, carbohydrate, lipids and insoluble fibers.
Its sterilization process consistently demonstrates a 6 LOG10/ml bacterial spores’ reduction, which complies with STAATT level IV, according to the ISTAATT guidelines (both in the liquid and solid phases). Currently, the Envomed 80 is the only on-site medical waste treatment technology approved by the Israeli Ministry of Health due to the above comprehensive validation requirements.
About HUS Helsinki University Hospital
HUS is the biggest health care provider and the second largest employer in Finland. More than half a million patients receive medical care at the HUS Helsinki University Hospital every year.
With 25,000 professionals working for the best of all patients, HUS is responsible for providing specialized health care for the residents of its 24 member municipalities. In addition, the treatment of many rare and severe diseases is nationally centralized to HUS.